These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3485230

  • 1. [New clues to the etiology of Parkinson disease: parkinsonism induced by the neurotoxin MPTP].
    Jonsson G, Sundström E.
    Lakartidningen; 1986 Jan 22; 83(4):215-8. PubMed ID: 3485230
    [No Abstract] [Full Text] [Related]

  • 2. [Pethidine and parkinsonism. 1-Metyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a new neurotoxin].
    Hunskår S.
    Tidsskr Nor Laegeforen; 1986 Jan 30; 106(3):219-20. PubMed ID: 3485316
    [No Abstract] [Full Text] [Related]

  • 3. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH, Samantaray S, Varghese M, Srinivasan A, Galoyan AA, Mohanakumar KP.
    Neuropeptides; 2006 Aug 30; 40(4):291-8. PubMed ID: 16712929
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y, Nagatsu T.
    Tanpakushitsu Kakusan Koso; 1986 Apr 30; 31(5):398-409. PubMed ID: 3520683
    [No Abstract] [Full Text] [Related]

  • 5. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA, Kaczmarczyk SJ, Solopotias T, Rowe P, Kalnins RM, Vajda FJ, Mendelsohn FA.
    Clin Exp Neurol; 1986 Apr 30; 22():155-64. PubMed ID: 3495376
    [Abstract] [Full Text] [Related]

  • 6. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
    Matsubara K.
    Nihon Hoigaku Zasshi; 1998 Oct 30; 52(5):301-5. PubMed ID: 10077975
    [Abstract] [Full Text] [Related]

  • 7. A simple quantitative bradykinesia test in MPTP-treated mice.
    Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y.
    Res Commun Chem Pathol Pharmacol; 1985 Dec 30; 50(3):435-41. PubMed ID: 3878557
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice.
    Rajeswari A, Sabesan M.
    Inflammopharmacology; 2008 Apr 30; 16(2):96-9. PubMed ID: 18408903
    [Abstract] [Full Text] [Related]

  • 12. [Etiopathogeny of Parkinson disease. The MPTP revolution].
    Sampaio C, Castro Caldas A.
    Acta Med Port; 1988 Apr 30; 1(4-6):304-7. PubMed ID: 3073646
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [L-threo-DOPS therapy and parkinsonism].
    Narabayashi H.
    No To Shinkei; 1986 Jan 30; 38(1):60-2. PubMed ID: 3083844
    [No Abstract] [Full Text] [Related]

  • 17. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
    Boireau A, Dubédat P, Bordier F, Peny C, Miquet JM, Durand G, Meunier M, Doble A.
    Neuroreport; 1994 Dec 20; 5(18):2657-60. PubMed ID: 7696626
    [Abstract] [Full Text] [Related]

  • 18. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun 20; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 19. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S.
    Nat Med; 1999 Dec 20; 5(12):1403-9. PubMed ID: 10581083
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.